Low dose, high dose, or no dose: better prescribing of cholinesterase inhibitors for Alzheimer's disease

Publisher： Cambridge University Press

E-ISSN： 1741-203x|25|4|511-515

ISSN： 1041-6102

Source： International Psychogeriatrics, Vol.25, Iss.4, 2013-02, pp. : 511-515

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The evidence for the efficacy of cholinesterase inhibitors in the treatment of Alzheimer's disease is convincing

By  

International Psychogeriatrics, Vol. 20, Iss. 2, 2008-04 ,pp. : 279-286

Cambridge University Press

Access to resources Recommend Favorite

Efficacy of SSRIs on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors

By  

International Psychogeriatrics, Vol. 22, Iss. 1, 2010-02 ,pp. : 114-119

Cambridge University Press

Access to resources Recommend Favorite

FOR DEBATE: IS THE EVIDENCE FOR THE EFFICACY OF CHOLINESTERASE INHIBITORS IN THE SYMPTOMATIC TREATMENT OF ALZHEIMER'S DISEASE CONVINCING OR NOT?

By  

International Psychogeriatrics, Vol. 20, Iss. 2, 2008-04 ,pp. : 259-260

Cambridge University Press

Access to resources Recommend Favorite

Initial cognitive response to cholinesterase inhibitors and subsequent long-term course in patients with mild Alzheimer's disease

By  

International Psychogeriatrics, Vol. 27, Iss. 8, 2015-08 ,pp. : 1323-1333

Cambridge University Press

Access to resources Recommend Favorite

The effect of cholinesterase inhibitors on decline in multiple functional domains in Alzheimer's disease: a two-year observational study in the Sunnybrook dementia cohort

By  

International Psychogeriatrics, Vol. 20, Iss. 6, 2008-12 ,pp. : 1141-1159

Cambridge University Press

Access to resources Recommend Favorite